文献速递腹部CT

碘叠加图改善腹膜癌病与良性腹膜病变的鉴别

Iodine overlays to improve differentiation between peritoneal carcinomatosis and benign peritoneal lesions.
PubMed 文献 · Eur Radiol · 2020-03-03

本研究纳入30例腹膜癌病(PC)和30例良性腹膜改变(BPA)患者,比较常规图像(CI)与CI联合碘叠加图(CI/IO)对PC的诊断效能。CI/IO较单用CI显著提高特异度(0.86 vs 0.78,p≤0.05),敏感度相当(0.79 vs 0.81,p=1),术后患者特异度提升最明显(0.93 vs 0.80,p≤0.05)。

要点

  • CI/IO较单用CI提高PC诊断特异度(0.86 vs 0.78,p≤0.05),敏感度相当。
  • 术后患者中CI/IO特异度提升最明显(0.93 vs 0.80,p≤0.05),有助避免假阳性。
  • 碘叠加图应作为常规图像的补充而非替代,单用IO图像质量与可评估性较低。

核心结论

  • 与单用常规图像相比,常规图像联合碘叠加图在敏感度相当的情况下提高了腹膜癌病评估的特异度,尤其在术后患者中。

研究设计与样本

  • 纳入30例腹膜癌病患者和30例良性腹膜改变患者,均行门静脉期腹部光谱探测器CT(SDCT)检查。
  • 由4名放射科医师分两次独立评估,两次间隔6周,分别仅用常规图像和常规图像联合碘叠加图。
  • 采用5点Likert量表评估病灶显示清晰度、诊断信心和图像质量,并以ROI为基础测量碘摄取和HU衰减进行定量分析。

关键影像表现/征象

  • 常规图像联合碘叠加图的病灶显示清晰度评分高于单用常规图像(4(3-5)vs 3(3-4),p≤0.05)。
  • 诊断信心在两种评估方式间相当(均为4(3-5),p=0.5)。
  • 整体图像质量和可评估性评分以常规图像联合碘叠加图最高(CI/IO 5(4-5)vs CI 4(4-4)vs IO 4(3-4),p≤0.05)。

诊断标准与关键数值

  • 常规图像联合碘叠加图诊断腹膜癌病的特异度为0.86,单用常规图像为0.78(p≤0.05)。
  • 常规图像联合碘叠加图诊断腹膜癌病的敏感度为0.79,单用常规图像为0.81(p=1)。
  • 术后患者中,常规图像联合碘叠加图特异度为0.93,单用常规图像为0.80(p≤0.05)。
  • 定量鉴别腹膜癌病与良性腹膜改变的AUC:碘定量为0.95,HU衰减为0.90。

临床应用与阅片要点

  • 阅片时可将碘叠加图与常规图像联合使用,以提高腹膜癌病诊断特异度,尤其在术后患者中。
  • 碘叠加图应作为常规图像的补充而非替代,单用碘叠加图的图像质量和可评估性低于常规图像。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Peritoneal carcinomatosis (PC) is a prognostically relevant metastatic disease which may be difficult to depict in postoperative patients, particularly in early stages. This study aimed to determine whether PC could be diagnosed more accurately when using a combination of spectral detector CT (SDCT)-derived conventional images (CI) and iodine overlay images (IO) compared with CI only.

METHODS: Thirty patients with PC and 30 patients with benign peritoneal alterations (BPA) who underwent portal-venous abdominal SDCT were included. Four radiologists determined the presence/absence of PC for each patient and assessed lesion conspicuity, diagnostic certainty, and image quality using 5-point Likert scales. Subjective assessment was conducted in two sessions comprising solely CI and CI/IO between which a latency of 6 weeks was set. Iodine uptake and HU attenuation were determined ROI-based to analyze quantitative differentiation of PC/BPA.

RESULTS: Specificity for PC was significantly higher when using CI/IO compared with using CI only (0.86 vs. 0.78, p ≤ 0.05), while sensitivity was comparable (0.79 vs. 0.81, p = 1). In postoperative patients, the increase in specificity was the highest (0.93 vs. 0.80, p ≤ 0.05). Lesion conspicuity was rated higher in CI/IO (4 (3-5)) compared with that in CI only (3 (3-4); p ≤ 0.05). Diagnostic certainty was comparable (both 4 (3-5); p = 0.5). CI/IO received the highest rating for overall image quality and assessability (CI/IO 5 (4-5) vs. CI 4 (4-4) vs. IO 4 (3-4); p ≤ 0.05). Area under the receiver operating characteristics curve (AUC) for quantitative differentiation between PC and BPA was higher for iodine (AUCIodine = 0.95, AUCHU = 0.90).

CONCLUSIONS: Compared with CI, combination of CI/IO improves specificity in the assessment of peritoneal carcinomatosis at comparable sensitivity, particularly in postoperative patients.

KEY POINTS: • Combination of iodine overlays and conventional images improves specificity when assessing patients with peritoneal carcinomatosis at comparable sensitivity. • Particularly in postsurgical patients, iodine overlays could help to avoid false-positive diagnosis of peritoneal disease. • Iodine overlays alone provided inferior image quality and assessability than conventional images, while the combination of both received the highest ratings. Iodine overlays should therefore be used in addition to and not as a substitute for conventional images.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lennartz S, Zopfs D, Abdullayev N, et al. Iodine overlays to improve differentiation between peritoneal carcinomatosis and benign peritoneal lesions. Eur Radiol. 2020. PMID: 32125516. doi:10.1007/s00330-020-06729-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。